A new study conducted by researchers from the Institute of Modern Physics of the Chinese Academy of Sciences  has uncovered a key mechanism involving Intermolecular Coulombic Decay in aqueous ...

LANZHOU -- A recent study has made significant progress in uncovering the microscopic mechanism behind heavy-ion cancer therapy, which is expected to optimize cancer treatment strategies and ...

Tri-Service General Hospital in Taiwan has entered a contract with Ion Beam Applications (IBA) for a ProteusONE compact ...

Heavy-ion therapy, one of the most advanced radiotherapy techniques, has proven to be more effective than conventional X-rays and proton radiation in cancer treatment. However, the mechanisms ...

A recent study has made significant progress in uncovering the microscopic mechanism behind heavy-ion cancer therapy, which is expected to optimize cancer treatment strategies and promote the ...

New Delhi: A recent study has made significant progress in uncovering the microscopic mechanism behind heavy-ion cancer ...

Louvain-la-Neuve, Belgium, 04 April, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, will be hosting a Capital Markets Day (CMD) this coming ...

IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today ...

A recent study led by the Universitat Autònoma de Barcelona (UAB) demonstrates the potential of gene therapy to restore motor ...

Hubble Therapeutics LLC a patient-focused biotechnology company developing a gene therapy to cure pediatric blindness, announces the successful ...